Dolby Laboratories (NYSE:DLB – Get Free Report) SVP John Couling sold 7,667 shares of the firm’s stock in a transaction that occurred on Monday, August 3rd. The shares were sold at an average price of $60.00, for a total value of $460,020.00. Following the completion of the transaction, the senior vice president directly owned 118,727 shares in the company, valued at $7,123,620. The trade was a 6.07% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which can be accessed through this hyperlink.
Dolby Laboratories Stock Up 0.1%
Shares of Dolby Laboratories stock opened at $61.31 on Thursday. Dolby Laboratories has a 12-month low of $48.26 and a 12-month high of $75.66. The stock has a 50 day moving average price of $52.59 and a two-hundred day moving average price of $58.48. The stock has a market capitalization of $5.80 billion, a P/E ratio of 26.09 and a beta of 0.80.
Dolby Laboratories (NYSE:DLB – Get Free Report) last released its quarterly earnings results on Thursday, July 30th. The electronics maker reported $0.69 EPS for the quarter, beating analysts’ consensus estimates of $0.67 by $0.02. Dolby Laboratories had a net margin of 16.70% and a return on equity of 11.08%. The company had revenue of $305.00 million for the quarter, compared to analyst estimates of $311.96 million. During the same quarter last year, the firm posted $0.78 earnings per share. The company’s quarterly revenue was down 3.3% compared to the same quarter last year. Dolby Laboratories has set its FY 2026 guidance at 4.250-4.400 EPS and its Q4 2026 guidance at 1.130-1.280 EPS. Sell-side analysts anticipate that Dolby Laboratories will post 3.21 earnings per share for the current year.
Dolby Laboratories Dividend Announcement
Dolby Laboratories declared that its Board of Directors has approved a stock repurchase program on Thursday, July 30th that permits the company to repurchase $350.00 million in outstanding shares. This repurchase authorization permits the electronics maker to buy up to 7% of its stock through open market purchases. Stock repurchase programs are often a sign that the company’s board of directors believes its stock is undervalued.
Analysts Set New Price Targets
A number of equities research analysts have issued reports on the stock. Rosenblatt Securities restated a “buy” rating and set a $85.00 price target on shares of Dolby Laboratories in a report on Friday, July 31st. Wall Street Zen lowered Dolby Laboratories from a “buy” rating to a “hold” rating in a research note on Saturday, August 1st. Barrington Research reissued an “outperform” rating and set a $90.00 price objective on shares of Dolby Laboratories in a research report on Monday, June 15th. Finally, Weiss Ratings restated a “hold (c-)” rating on shares of Dolby Laboratories in a research note on Wednesday, June 24th. Three investment analysts have rated the stock with a Buy rating and two have issued a Hold rating to the company’s stock. According to data from MarketBeat, the company presently has a consensus rating of “Moderate Buy” and a consensus price target of $90.75.
Read Our Latest Research Report on Dolby Laboratories
Institutional Trading of Dolby Laboratories
Several hedge funds and other institutional investors have recently bought and sold shares of DLB. State Street Corp raised its position in shares of Dolby Laboratories by 8.7% during the second quarter. State Street Corp now owns 2,261,059 shares of the electronics maker’s stock valued at $167,906,000 after buying an additional 180,072 shares during the last quarter. First Trust Advisors LP grew its position in Dolby Laboratories by 19.9% during the first quarter. First Trust Advisors LP now owns 2,254,933 shares of the electronics maker’s stock worth $135,431,000 after buying an additional 374,405 shares in the last quarter. Geode Capital Management LLC increased its stake in Dolby Laboratories by 15.6% during the fourth quarter. Geode Capital Management LLC now owns 1,885,246 shares of the electronics maker’s stock valued at $122,749,000 after acquiring an additional 254,250 shares during the period. AQR Capital Management LLC increased its stake in Dolby Laboratories by 51.8% during the second quarter. AQR Capital Management LLC now owns 1,736,260 shares of the electronics maker’s stock valued at $128,935,000 after acquiring an additional 592,282 shares during the period. Finally, Snyder Capital Management L P raised its holdings in Dolby Laboratories by 24.4% in the 4th quarter. Snyder Capital Management L P now owns 1,427,093 shares of the electronics maker’s stock valued at $91,648,000 after acquiring an additional 279,743 shares in the last quarter. 58.56% of the stock is currently owned by institutional investors and hedge funds.
Dolby Laboratories Company Profile
Dolby Laboratories, Inc is a global leader in audio and imaging technologies, specializing in the development, licensing and deployment of solutions that enhance entertainment and communications experiences. The company’s core business revolves around creating advanced audio codecs, noise reduction systems and spatial sound technologies for a wide range of applications, including cinema, broadcast, gaming, streaming and personal devices. Dolby’s licensing model enables consumer electronics manufacturers, content creators and service providers to integrate its technologies into products such as televisions, smartphones, home theater systems and set-top boxes.
Among its flagship innovations are Dolby Atmos, an immersive audio format that delivers three-dimensional soundscapes for theaters and home systems; Dolby Digital and Dolby Digital Plus, widely adopted audio compression formats for broadcast and streaming; and Dolby Vision, a high-dynamic-range imaging technology that expands color, contrast and brightness in displays.
Featured Articles
- Five stocks we like better than Dolby Laboratories
- SpaceX: Love the Company, But the Stock Is a Harder Call
- Ulta’s Growth Is Real, But So Are the Risks
- BWX Technologies Is Turning the AI Power Problem Into a Nuclear Growth Story
- Meta’s Earnings Drop Shows Wall Street Wants More Than Ad Growth
Receive News & Ratings for Dolby Laboratories Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Dolby Laboratories and related companies with MarketBeat.com's FREE daily email newsletter.
